Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study (Q43237133)
Jump to navigation
Jump to search
scientific article published on 20 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study |
scientific article published on 20 November 2009 |
Statements
1 reference
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study (English)
1 reference
Jeffrey A Meyerhardt
1 reference
Charles S Fuchs
1 reference
Andrew X Zhu
1 reference
Lawrence S Blaszkowsky
1 reference
Avinash R Kambadakone
1 reference
Alona Muzikansky
1 reference
Hui Zheng
1 reference
Jeffrey W Clark
1 reference
Thomas A Abrams
1 reference
Jennifer A Chan
1 reference
Peter C Enzinger
1 reference
Pankaj Bhargava
1 reference
Eunice L Kwak
1 reference
Jill N Allen
1 reference
Sanjay R Jain
1 reference
Keith Stuart
1 reference
Kerry Horgan
1 reference
Susan Sheehan
1 reference
David P Ryan
1 reference
Dushyant V Sahani
1 reference
20 November 2009
1 reference
1 reference
11
1 reference
1
1 reference
48-54
1 reference
Identifiers
1 reference
1 reference